Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
49.23
-3.09 (-5.91%)
Sep 29, 2026, 12:28 PM EDT - Market open

Pulse Biosciences Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Pulse Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $54. The average 1-year stock price forecast is 9.69% higher than the current stock price, while the lowest is $35 (-28.91%) and the highest is $73 (+48.28%).

Price Target: $54 (+9.69%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$35$54$51.5$73
Change-28.91%+9.69%+4.61%+48.28%

Analyst Ratings

The average analyst rating for Pulse Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy223335
Buy000011
Hold000000
Sell000000
Strong Sell000000
Total223346

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Buy
Initiates
$70
BuyInitiates$70+42.19%Sep 23, 2026
Freedom Capital Markets
Freedom Capital Markets
Buy
Initiates
$73
BuyInitiates$73+48.28%Sep 9, 2026
Needham
Needham
Buy
Initiates
$13 → $58
BuyInitiates$13 → $58+17.81%Aug 17, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$43
BuyMaintains$43-12.65%Aug 10, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$30 → $45
BuyMaintains$30 → $45-8.59%Aug 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.02M
from 350.00K
Increased by 477.71%
Revenue Next Year
6.73M
from 2.02M
Increased by 233.00%
EPS This Year
-1.11
from -0.75
EPS Next Year
-1.17
from -1.11
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.42M700.00K--350.00K2.02M
Revenue Growth
--50.64%---477.71%
Operating Income
-63.01M-58.06M-43.57M-56.26M-76.94M-88.08M
Net Income
-63.66M-58.51M-42.21M-53.59M-72.78M-95.70M
EPS
-----0.75-1.11
Free Cash Flow
-----54.44M-70.70M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.3M
Avg2.0M
Low1.6M

Revenue Growth

Revenue Growth202620272028
High
542.9%
Avg
477.7%
Low
357.1%

EPS Forecast

EPS202620272028
High-1.09
Avg-1.11
Low-1.13

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-